Eurofarma Synapsis, sponsor of the B2B Scale-up, announces the 16 selected companies
Published in: May 21, 2020
and updated in: November 4, 2021
Listen to the text
Stop the audio
São Paulo, May 2020 – Eurofarma, the Brazilian multinational pharmaceutical company that most heavily invests in innovation through its Eurofarma Synapsis acceleration program, announces the 16 companies selected for the B2B Scale-up, led by Endeavor, a global organization to support entrepreneurs. The pharmaceutical company is one of the Gold sponsors of the project.
Registration for the program included over 300 companies from several different fields. From now on, the selected companies will undergo a series of collective and individual mentoring sessions, with the best names in the market of the Endeavor network and its key sponsors, including Eurofarma. The pharmaceutical company’s relationship network, for example, includes more than 4,000 suppliers, 1,500 active customers (B2B) and over 600,000 medical contacts per month, encompassing all specialties, for startups focused on the health sector.
“It is gratifying to see the sheer amount of companies interested in the Synapsis program across the country. We are proud to be the leading pharmaceutical company in terms of innovation investments in Brazil, also supporting scientists and entrepreneurs. We want to bring the national industry closer to disruptive innovation,” explains Helton Carvalho, director of Entrepreneurship and Digital at the pharmaceutical company.
“Endeavor selected 16 companies that we believe to be the best in the B2B sector. These businesses combine strong execution and good product, in addition to having clear growth indicators that highlight them as major future players in the segment. Our role is to accelerate this growth, minimizing the main challenges,” says Victor Xavier, Endeavor’s acceleration manager. “Our sponsors play an essential role in the program, validating whether, in fact, the pains that the selected companies are looking to resolve in the market are also valid within major corporations, that is, helping to legitimize whether the product market fit of scale-ups is aligned with what the market needs”, he adds.
About Eurofarma Group
As the first multinational pharmaceutical company with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 313 products, 649 dosage forms, serves 25 medical specialties and covers 89 therapeutic classes, which represent 81% of prescriptions in the brand market.
The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported sales totaled BRL 5.6 billion in 2019 and the Group employs over 7,000 employees.
About Endeavor
Endeavor is a global non-profit organization with the mission of accelerating entrepreneurs who accelerate the country’s growth. Operating in Brazil since 2000, it promotes a business environment that stimulates the growth and impact of entrepreneurs heading scale-ups, high-growth companies with scalable and innovative models.
Thus, it is decisive in generating over 48,000 jobs and BRL 9 billion in revenue annually, through support and acceleration programs affecting over 600 entrepreneurs. In 20 years of operation in Brazil, the organization also influences the emergence of public policies that simplify the Brazilian business environment, paving the way for the growth of companies that can be essential for the country’s growth as well.
Registration for the program included over 300 companies from several different fields. From now on, the selected companies will undergo a series of collective and individual mentoring sessions, with the best names in the market of the Endeavor network and its key sponsors, including Eurofarma. The pharmaceutical company’s relationship network, for example, includes more than 4,000 suppliers, 1,500 active customers (B2B) and over 600,000 medical contacts per month, encompassing all specialties, for startups focused on the health sector.
“It is gratifying to see the sheer amount of companies interested in the Synapsis program across the country. We are proud to be the leading pharmaceutical company in terms of innovation investments in Brazil, also supporting scientists and entrepreneurs. We want to bring the national industry closer to disruptive innovation,” explains Helton Carvalho, director of Entrepreneurship and Digital at the pharmaceutical company.
“Endeavor selected 16 companies that we believe to be the best in the B2B sector. These businesses combine strong execution and good product, in addition to having clear growth indicators that highlight them as major future players in the segment. Our role is to accelerate this growth, minimizing the main challenges,” says Victor Xavier, Endeavor’s acceleration manager. “Our sponsors play an essential role in the program, validating whether, in fact, the pains that the selected companies are looking to resolve in the market are also valid within major corporations, that is, helping to legitimize whether the product market fit of scale-ups is aligned with what the market needs”, he adds.
| Learn more on the selected scale-ups and operating areas: | |
| Accountfy | An integrated solutions platform that focuses on controllership activities and financial planning. |
| Convenia | Data intelligence platform that ensures that the company manages information and automates a number of DP processes, taking data through the API to other platforms and benefit providers. |
| Digibee | Platform that resolves integration challenges and drives digital business without a single line of code. |
| DTI Digital | Revolutionary Squads as a Service platform that drives digital business transformation. |
| Flipside | Cybersecurity solutions ecosystem. |
| Hash | Platform of white-label and plug-and-play solutions for the provision of financial services. |
| Intelipos | Leading Brazilian platform in freight management. It uses smart solutions to integrate shippers (such as e-commerce, retail and industry) and carriers, providing a comprehensive view of deliveries. |
| Intellibrand | Innovative platform focused on digital marketing and data solutions to help brands sell smarter. |
| Kenoby | SaaS software for end-to-end service across the entire field of recruitment and selection, from a position request and disclosure of vacancies through integrations and reports, completely eliminating the use of Excel. |
| MercaFácil | Consumer behavior management platform that uses big data, data mining and geolocation technologies to create software focused on the management of purchasing behavior for retailers throughout Brazil. |
| Nuveo | Proprietary platform that offers an end-to-end solution in process automation. |
| RIO Analytics | Combining advanced industrial analytics and artificial intelligence, RIO Analytics developed a digital platform capable of predicting faults, reducing downtime and increasing operational efficiency. |
| Rocket Chat | Rocket.Chat is a fast-growing enterprise communications and collaboration platform that is now installed on more than 180,000 servers and has more than 10 million users worldwide. |
| Senha Segura | Platform that develops and stores a password vault for privileged access protection (PASM). |
| Squid | Squid is the first influence marketing platform in Brazil specialized in micro influencers. |
| Xerpa | Application that allows employees to access their wages when needed, in an on-demand model. |
About Eurofarma Group
As the first multinational pharmaceutical company with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 313 products, 649 dosage forms, serves 25 medical specialties and covers 89 therapeutic classes, which represent 81% of prescriptions in the brand market.
The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported sales totaled BRL 5.6 billion in 2019 and the Group employs over 7,000 employees.
About Endeavor
Endeavor is a global non-profit organization with the mission of accelerating entrepreneurs who accelerate the country’s growth. Operating in Brazil since 2000, it promotes a business environment that stimulates the growth and impact of entrepreneurs heading scale-ups, high-growth companies with scalable and innovative models.
Thus, it is decisive in generating over 48,000 jobs and BRL 9 billion in revenue annually, through support and acceleration programs affecting over 600 entrepreneurs. In 20 years of operation in Brazil, the organization also influences the emergence of public policies that simplify the Brazilian business environment, paving the way for the growth of companies that can be essential for the country’s growth as well.